NFKB1 and prostate carcinoma: Concordant, the GSEA revealed enriched expression of mechanisms and signaling, commonly reported within more aggressive forms of prostate cancer, including EMT, coupled with enriched inflammatory responses, TGF-β receptor signaling and TNFα signaling via NF-kB.